All Q4 FY26 results →
IA

Inflame Applian.

Q4 FY26Consumer Durables

Inflame Appliances Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹242
Market cap₹164 Cr
P/E28.5
Updated25 Aug 2026
Read4 min read

What the Q4 FY26 call signalled

3 of 4 strong

RevenueStrong growth
MarginMargins steady
CapexCapex planned
Order bookOrder book rising

The short version

Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements. Targeting 50% revenue growth for FY27, with a revenue aim of INR400+ crores by FY28.

From Inflame Applian.'s Q4 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Strong growth
  • Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements.
  • Expect to achieve INR 400 crores+ revenue by FY28 with ramped-up product lines and completed facility expansion.
  • Projected revenue to reach around INR 500 crores in FY28 or FY29.
  • Target of producing 4 lakh chimneys in FY27, up from 2.7 lakh in the previous year, aligning with 50% growth.
  • Gradual ramp-up in manufacturing capacity, especially for built-in refrigerators, wine coolers, ovens, dishwashers, and microwaves by 2027.

2 more points from Inflame Applian.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Inflame Applian. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Panchkula Plant Expansion:
  • INR 8-10 crore capex underway.
  • One part of the plant completed and operational.
  • Ground floor to be utilized imminently.
  • First and second floors under construction, expected ready by mid-August and end-September 2026 respectively.
  • Glass Plant Automation:
  • Plan for a zero-manpower glass plant with 250% production increase post INR 250-300 crore investment.
  • Discussions and supplier visits already conducted.
  • Joint Venture & Backward Integration:
  • Inflame holds 34% in Tricoree Machmatrix Pvt. Ltd.
  • Focus on electronics, IoT-enabled products, BLDC motor manufacturing.
  • Setup for backward integration to reduce dependency on Chinese imports.
  • First phase: BLDC motors.
  • Second phase: electronics (PCBA, switches).
  • Future: IoT-enabled smart control solutions.

2 more points from Inflame Applian.'s call on capex

Create a free account to keep reading this call

Top-ranked in Consumer Durables

Ranked on what management guided this quarter

Guidance-ranked
1Nanta Tech
Rev 1Mar 1
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 2
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Inflame Applian. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book rising
  • Orders are typically firm only for one month; longer-term firm orders (2-3 months) are not common.
  • The company closely tracks expected monthly orders from key customers like Hindware, Havells, and KAFF based on market share and demand.
  • Currently, the company has a comfortable order position with more orders than the planned growth rate.
  • Unexecuted orders occur due to component delays or shipping issues but are generally managed efficiently.
  • The order book is healthy, with a good outlook for the next 2-3 months.
  • Recent months have shown growth trending positively with month-on-month improvement.

2 more points from Inflame Applian.'s call on order book

Create a free account to keep reading this call

What Inflame Applian.'s management said in earlier quarters

Others in Consumer Durables this season

  • Sonam Ltd (Q4 FY26)

    Working capital cycle is efficient (29 days debtors, 37 days creditors); cash flow remains strong with 70%-80% sales in advance or credit to old customers. Key…

  • Global Surfaces Ltd (Q4 FY26)

    Q4-FY26 Revenue from Operations: INR 454 Mn, down 21.0% YoY from INR 575 Mn in Q4-FY25 (Page 22). Key investor presentation takeaways from Global Surfaces's Q4

  • Naman Industries Proxima Limited (Q4 FY26)

    Revenue from operations for H2 FY26 was ₹73.6 Cr, down 17.4% YoY from ₹89.1 Cr in H2 FY25. Key investor presentation takeaways from Naman Industries Proxima's Q

  • Yash Optics & Lens Ltd (Q4 FY26)

    Q4/FY26 Revenue from Operations: ₹3,061.4 Lacs (H2 FY26), up 29.1% YoY compared to ₹2,370.8 Lacs in H2 FY25 (Page 26). Key investor presentation takeaways from

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Inflame Applian. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Inflame Applian. Q4 FY26 results?

Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements. Targeting 50% revenue growth for FY27, with a revenue aim of INR400+ crores by FY28.

What is Inflame Applian. share price analysis?

Inflame Applian. currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 28.5 with a market cap of ₹164 Cr. Investors should review the full earnings analysis for detailed insights.

Is Inflame Applian. planning capital expenditure?

Panchkula Plant Expansion: - INR 8-10 crore capex underway. - One part of the plant completed and operational. - Ground floor to be utilized imminently. - First and second floors under construction, expected ready by mid-August and end-September 2026 respectively. - Glass Plant Automation: - Plan for a zero-manpower glass plant with 250% production increase post INR 250-300 crore investment. - Discussions and supplier visits already conducted. - Joint Venture & Backward Integration: - Inflame holds 34% in Tricoree Machmatrix Pvt.

Keep Inflame Applian. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.